REGIME POSOLOGIQUE

• 收藏
• 分享

专利权人:

GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED

发明人:

REID, JULIET,SADDIC, GEORGE,ZAMUNER, STEFANO,ZECCHIN, CHIARA

申请号：

CA3035296

公开号：

CA3035296A1

申请日:

2017.08.29

申请国别(地区):

CA

年份:

2018

代理人:

摘要：

The present invention provides pharmaceutical compositions comprising antigen binding proteins that specifically bind Oncostatin M (OSM) and in particular human OSM (hOSM) and which inhibit the binding of OSM to the gp130 receptor,novel therapeutic regimens for said pharmaceutical compositions； and methods for administering said pharmaceutical compositions in the treatment of an inflammatory or autoimmune disorder, in particular in the treatment of systemic sclerosis.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/